Drugmakers pour $40 million into healthcare reform debate

Statistics show that the Pharmaceutical Research and Manufacturers of America (PhRMA), a lobbying group that represents 32 brandname drug companies, and its member companies have spent $40 million lobbying Congress as the lawmakers work to overhaul the U.S. healthcare system.